TickerFacts.

Panacea Life Sciences Holdings, Inc. (PLSH): Operating Income

Annual figures by period end, from SEC filings.

Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2019-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$5.55M
Year ended 2023-12-31
2014-12-31: -$420.3K2015-12-31: -$389.3K2016-12-31: -$1.60M2017-12-31: -$3.12M2018-12-31: -$2.44M2019-12-31: -$10.67M2020-12-31: -$5.26M2021-12-31: -$5.94M2022-12-31: -$5.65M2023-12-31: -$5.55M-$5.55M
2014-12-31 Operating Income (USD) 2023-12-31
Period endedOperating IncomeChange YoYSource filing
2023-12-31-$5.55Mn/m2024-04-01, From 2023-01-01
2022-12-31-$5.65Mn/m2024-04-01, From 2022-01-01
2021-12-31-$5.94Mn/m2023-03-30, From 2021-01-01
2020-12-31-$5.26Mn/m2022-03-31, From 2020-01-01
2019-12-31-$10.67Mn/c2021-04-23, From 2019-01-01
2018-12-31-$2.44Mn/m2020-05-22, From 2018-01-01
2017-12-31-$3.12Mn/m2019-03-29, From 2017-01-01
2016-12-31-$1.60Mn/m2018-04-02, From 2016-01-01
2015-12-31-$389.3Kn/m2017-03-31, From 2015-01-01
2014-12-31-$420.3Kn/a2016-02-29, From 2014-01-01